NASDAQ:NKTR

Nektar Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy NKTR

*Your capital is at risk

$59.23

+0.670 (+1.14%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

NKTR Prediction Chart

NKTR Predictions History

Latest community submissions for NKTR.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JuanC Villegas Pro	Jul 25, 2017	$22.58 -2.80%	$23.23	X	97.20%	0
JS Pro	Apr 19, 2017	$18.44 -0.91%	$18.61	X	99.10%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NKTR with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT NEKTAR THERAPEUTICS

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by